Cargando…

Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis

Osteoarthritis (OA) is a degenerative joint disease and an important cause of incapacitation. There is a lack of drugs and effective treatments that stop or slow the OA progression. Modern pharmacological treatments, such as analgesics, have analgesic effects but do not affect the course of OA. Long...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukhikh, Stanislav, Noskova, Svetlana, Ivanova, Svetlana, Ulrikh, Elena, Izgaryshev, Alexsander, Babich, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074261/
https://www.ncbi.nlm.nih.gov/pubmed/33924083
http://dx.doi.org/10.3390/molecules26082391
_version_ 1783684315192754176
author Sukhikh, Stanislav
Noskova, Svetlana
Ivanova, Svetlana
Ulrikh, Elena
Izgaryshev, Alexsander
Babich, Olga
author_facet Sukhikh, Stanislav
Noskova, Svetlana
Ivanova, Svetlana
Ulrikh, Elena
Izgaryshev, Alexsander
Babich, Olga
author_sort Sukhikh, Stanislav
collection PubMed
description Osteoarthritis (OA) is a degenerative joint disease and an important cause of incapacitation. There is a lack of drugs and effective treatments that stop or slow the OA progression. Modern pharmacological treatments, such as analgesics, have analgesic effects but do not affect the course of OA. Long-term use of these drugs can lead to serious side effects. Given the OA nature, it is likely that lifelong treatment will be required to stop or slow its progression. Therefore, there is an urgent need for disease-modifying OA treatments that are also safe for clinical use over long periods. Phytonutraceuticals are herbal products that provide a therapeutic effect, including disease prevention, which not only have favorable safety characteristics but may have an alleviating effect on the OA and its symptoms. An estimated 47% of OA patients use alternative drugs, including phytonutraceuticals. The review studies the efficacy and action mechanism of widely used phytonutraceuticals, analyzes the available experimental and clinical data on the effect of some phytonutraceuticals (phytoflavonoids, polyphenols, and bioflavonoids) on OA, and examines the known molecular effect and the possibility of their use for chondroprotection.
format Online
Article
Text
id pubmed-8074261
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80742612021-04-27 Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis Sukhikh, Stanislav Noskova, Svetlana Ivanova, Svetlana Ulrikh, Elena Izgaryshev, Alexsander Babich, Olga Molecules Review Osteoarthritis (OA) is a degenerative joint disease and an important cause of incapacitation. There is a lack of drugs and effective treatments that stop or slow the OA progression. Modern pharmacological treatments, such as analgesics, have analgesic effects but do not affect the course of OA. Long-term use of these drugs can lead to serious side effects. Given the OA nature, it is likely that lifelong treatment will be required to stop or slow its progression. Therefore, there is an urgent need for disease-modifying OA treatments that are also safe for clinical use over long periods. Phytonutraceuticals are herbal products that provide a therapeutic effect, including disease prevention, which not only have favorable safety characteristics but may have an alleviating effect on the OA and its symptoms. An estimated 47% of OA patients use alternative drugs, including phytonutraceuticals. The review studies the efficacy and action mechanism of widely used phytonutraceuticals, analyzes the available experimental and clinical data on the effect of some phytonutraceuticals (phytoflavonoids, polyphenols, and bioflavonoids) on OA, and examines the known molecular effect and the possibility of their use for chondroprotection. MDPI 2021-04-20 /pmc/articles/PMC8074261/ /pubmed/33924083 http://dx.doi.org/10.3390/molecules26082391 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sukhikh, Stanislav
Noskova, Svetlana
Ivanova, Svetlana
Ulrikh, Elena
Izgaryshev, Alexsander
Babich, Olga
Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
title Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
title_full Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
title_fullStr Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
title_full_unstemmed Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
title_short Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
title_sort chondroprotection and molecular mechanism of action of phytonutraceuticals on osteoarthritis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074261/
https://www.ncbi.nlm.nih.gov/pubmed/33924083
http://dx.doi.org/10.3390/molecules26082391
work_keys_str_mv AT sukhikhstanislav chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis
AT noskovasvetlana chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis
AT ivanovasvetlana chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis
AT ulrikhelena chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis
AT izgaryshevalexsander chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis
AT babicholga chondroprotectionandmolecularmechanismofactionofphytonutraceuticalsonosteoarthritis